These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1725047)

  • 1. The cardiomyopathy of overload: a hypothesis.
    Katz AM
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S68-71. PubMed ID: 1725047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The heart in congestive failure.
    Katz AM
    Cardioscience; 1990 Mar; 1(1):3-6. PubMed ID: 2151711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is heart failure an abnormality of myocardial cell growth?
    Katz AM
    Cardiology; 1990; 77(5):346-56. PubMed ID: 2073654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
    Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of dilated cardiomyopathy with digitalis, diuretics and vasodilators].
    Liebau G
    Herz; 1985 Jun; 10(3):138-42. PubMed ID: 2991095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: effect of ACE inhibitors and other vasodilators].
    Langes K; Bleifeld W
    Herz; 1990 Jun; 15(3):164-70. PubMed ID: 2198217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maladaptive growth in the failing heart: the cardiomyopathy of overload.
    Katz AM
    Cardiovasc Drugs Ther; 2002 May; 16(3):245-9. PubMed ID: 12374903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart failure: an update on pathophysiology.
    Drexler H
    Arch Mal Coeur Vaiss; 1994 Jun; 87 Spec No 2():13-6. PubMed ID: 7864717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
    Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indications for ACE inhibitors in chronic heart failure].
    Erdmann E
    Z Kardiol; 1994; 83 Suppl 4():75-9. PubMed ID: 7856285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibitor captopril prevents volume overload cardiomyopathy in experimental chronic aortic valve regurgitation.
    Plante E; Gaudreau M; Lachance D; Drolet MC; Roussel E; Gauthier C; Lapointe E; Arsenault M; Couet J
    Can J Physiol Pharmacol; 2004 Mar; 82(3):191-9. PubMed ID: 15052285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normalization of ejection fraction and resolution of symptoms in chronic severe heart failure is possible with modern medical therapy: clinical observations in 11 patients.
    Harinstein ME; Berliner JI; Shah SJ; Taegtmeyer H; Gheorghiade M
    Am J Ther; 2008; 15(3):206-13. PubMed ID: 18496257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure: its progression and its therapy.
    Sonnenblick EH; LeJemtel TH
    Hosp Pract (Off Ed); 1993 Sep; 28(9):121-30. PubMed ID: 8366150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell death in the failing heart: role of an unnatural growth response to overload.
    Katz AM
    Clin Cardiol; 1995 Sep; 18(9 Suppl 4):IV36-44. PubMed ID: 7489619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should all patients with congestive heart failure and dilated cardiomyopathy be treated with vasodilators?
    Massie BM
    Cardiovasc Clin; 1990; 21(1):251-62; discussion 263-4. PubMed ID: 2199051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine idiopathic dilated cardiomyopathy. Part II: pathophysiology and therapy.
    Borgarelli M; Tarducci A; Tidholm A; Häggström J
    Vet J; 2001 Nov; 162(3):182-95. PubMed ID: 11681869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance in dilated cardiomyopathy.
    Shah A; Shannon RP
    Rev Cardiovasc Med; 2003; 4 Suppl 6():S50-7. PubMed ID: 14668703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy and course of dilated cardiomyopathy].
    Hess OM; Greminger P; Maire R; Turina J; Krayenbühl HP
    Schweiz Med Wochenschr; 1985 May; 115(20):693-7. PubMed ID: 3892658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac arrhythmias--a new indication for angiotensin-converting enzyme inhibitors?
    Wesseling H; de Graeff PA; van Gilst WH; Kingma JH; de Langen CD
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():89-95. PubMed ID: 2674445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.